Correlation Between Eton Pharmaceuticals and Blueprint Medicines
Can any of the company-specific risk be diversified away by investing in both Eton Pharmaceuticals and Blueprint Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eton Pharmaceuticals and Blueprint Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eton Pharmaceuticals and Blueprint Medicines Corp, you can compare the effects of market volatilities on Eton Pharmaceuticals and Blueprint Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eton Pharmaceuticals with a short position of Blueprint Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eton Pharmaceuticals and Blueprint Medicines.
Diversification Opportunities for Eton Pharmaceuticals and Blueprint Medicines
0.27 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Eton and Blueprint is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Eton Pharmaceuticals and Blueprint Medicines Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blueprint Medicines Corp and Eton Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eton Pharmaceuticals are associated (or correlated) with Blueprint Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blueprint Medicines Corp has no effect on the direction of Eton Pharmaceuticals i.e., Eton Pharmaceuticals and Blueprint Medicines go up and down completely randomly.
Pair Corralation between Eton Pharmaceuticals and Blueprint Medicines
Given the investment horizon of 90 days Eton Pharmaceuticals is expected to generate 1.52 times more return on investment than Blueprint Medicines. However, Eton Pharmaceuticals is 1.52 times more volatile than Blueprint Medicines Corp. It trades about 0.39 of its potential returns per unit of risk. Blueprint Medicines Corp is currently generating about 0.2 per unit of risk. If you would invest 842.00 in Eton Pharmaceuticals on August 29, 2024 and sell it today you would earn a total of 403.00 from holding Eton Pharmaceuticals or generate 47.86% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Eton Pharmaceuticals vs. Blueprint Medicines Corp
Performance |
| Timeline |
| Eton Pharmaceuticals |
| Blueprint Medicines Corp |
Eton Pharmaceuticals and Blueprint Medicines Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eton Pharmaceuticals and Blueprint Medicines
The main advantage of trading using opposite Eton Pharmaceuticals and Blueprint Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eton Pharmaceuticals position performs unexpectedly, Blueprint Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blueprint Medicines will offset losses from the drop in Blueprint Medicines' long position.| Eton Pharmaceuticals vs. Phibro Animal Health | Eton Pharmaceuticals vs. Procaps Group SA | Eton Pharmaceuticals vs. Amphastar P | Eton Pharmaceuticals vs. Alkermes Plc |
| Blueprint Medicines vs. Terns Pharmaceuticals | Blueprint Medicines vs. Amylyx Pharmaceuticals | Blueprint Medicines vs. Acumen Pharmaceuticals | Blueprint Medicines vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |